J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion
Business
•
November 16, 2026
•
3 views
Johnson & Johnson said it would acquire Ollin for $2.2 billion upfront, with the potential for milestone payments of up to about $1.13 billion.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



